Volume 16 Supplement 3

Sepsis 2012

Open Access

Clinical and diagnostic significance of apoptosis in the development of neutropenia and bacterial complications in newborns with respiratory distress syndrome

  • M Puchtinskaya1
Critical Care201216(Suppl 3):P33

DOI: 10.1186/cc11720

Published: 14 November 2012

Background

The development of neutropenia with neonates with RDS on mechanical ventilation is a sign of the realization of bacterial complications [1, 2]. The purpose of this study was the optimization of prevention of neonatal sepsis.

Methods

With permission of the Ethics Committee 64 full-term newborns with RDS on mechanical ventilation, without clinical signs of infection, were retrospectively divided into two groups: with a decrease in absolute neutrophil count (M <2,000 cells/mm3) after 3 to 5 days of hospitalization (I, n = 30) and non-neutropenic (II, n = 34). The survey was conducted at admission and 3 to 5 days. They were studied on the content of lymphocytes in the early (AnnexinV-FITC+PI-) and late (AnnexinV-FITC+PI+) apoptosis by flow cytometry (AnnexinV+-labeled FITK and propidium iodide (PI+)-labeled PE; Saltag, USA), taking into account results on the cytometer (Beckman Coulter Epics XL, USA); the plasma level of granulocyte colony-stimulating factor (GCSF), fibroblast growth factor (FGF), anti-apoptosis soluble sFas-ligand (sFas-L) by ELISA (Victor, Finland; test system Cytimmune Sciences Inc., USA and Bender MedSystems GmbH, Austria). Points of cutoff were determined by ROC analysis. The statistical power of the study is 80% (α ≤ 0.05).

Results

At admission, it was revealed that the patients in group I have a high content of lymphocytes in the early and late apoptosis, and low levels of GCSF, FGF, sFas-L in reference to group II (α ≤ 0.05). In group I, 27 patients at 3 to 5 days developed neutropenia (M <2,000 cells/mm3) and a reduction in plasma levels of GCSF, FGF, sFas-L and an increase in lymphocyte apoptosis (α ≤ 0.05). Sepsis developed in 22 children of group I and in only five patients of group II (α ≤ 0.05). The values of cutoff (sensitivity, specificity, accuracy) for prediction of neutropenia in neonates with RDS at admission to the ICU were: for GCSF - 1,556 pg/ml (85.1%, 75.6%, 79.6%, respectively); for sFAS-L - 5,870 pg/ml (69.56%, 74.4%, 71.9%); for FGF - 25.7 pg/ml (68%, 82%, 74.4%); for early apoptosis - 9.59% (82%, 93%, 74%); and for late apoptosis - 0.56% (94.1%, 98%, 85.3%).

Conclusion

Reduction of proliferative factors (GCSF, FGF, sFas-L) and activation of apoptotic lymphocytes are markers of neutropenia and are associated with the high incidence of sepsis in infants with RDS.

Authors’ Affiliations

(1)
Research Institute of Obstetrics and Pediatrics

References

  1. Finney SJ, Evans TW: Induction of apoptosis in sepsis: cell suicide may be beneficial. Crit Care Med 2002, 30: 261-262. 10.1097/00003246-200201000-00047View ArticlePubMedGoogle Scholar
  2. Puchtinskaya MG, Estrin VV: The criteria for appointment of a hour-GCSF infants with RDS. Russian J Perinatol Pediatr 2010, 6: 34-38.Google Scholar

Copyright

© Puchtinskaya; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement